Brandes Investment Partners LP Sells 28,890 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Brandes Investment Partners LP lowered its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 3.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 785,174 shares of the company’s stock after selling 28,890 shares during the period. Brandes Investment Partners LP’s holdings in Pediatrix Medical Group were worth $10,301,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of MD. Principal Financial Group Inc. boosted its holdings in Pediatrix Medical Group by 14.1% in the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock worth $5,953,000 after buying an additional 63,581 shares during the period. Atria Investments Inc boosted its holdings in shares of Pediatrix Medical Group by 9.0% during the 3rd quarter. Atria Investments Inc now owns 27,124 shares of the company’s stock valued at $314,000 after purchasing an additional 2,238 shares during the last quarter. Royce & Associates LP boosted its holdings in shares of Pediatrix Medical Group by 19.0% during the 3rd quarter. Royce & Associates LP now owns 197,372 shares of the company’s stock valued at $2,288,000 after purchasing an additional 31,482 shares during the last quarter. Empowered Funds LLC boosted its holdings in shares of Pediatrix Medical Group by 5.3% during the 3rd quarter. Empowered Funds LLC now owns 266,838 shares of the company’s stock valued at $3,093,000 after purchasing an additional 13,534 shares during the last quarter. Finally, Quest Partners LLC boosted its holdings in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after purchasing an additional 622 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Down 0.0 %

Shares of NYSE:MD opened at $13.71 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a 50-day moving average price of $14.16 and a 200 day moving average price of $13.41. The company has a market cap of $1.18 billion, a price-to-earnings ratio of -11.42, a PEG ratio of 1.74 and a beta of 1.48.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. As a group, equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have commented on MD. UBS Group increased their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Macquarie began coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective for the company. Truist Financial increased their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Finally, Mizuho increased their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.